Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform and health tracker devices. Its health tracker devices include Allurion Connected Scale and Allurion Health Tracker. Allurion Connected Scale offers a complete weight tracking experience, allowing users to monitor their weight, body mass index (BMI) and body composition. Allurion Health Tracker tracks steps, exercise and sleep. Allurion Virtual Care Suite is available to providers separately from the Allurion Program to help customize, monitor and manage weight-loss therapy for patients regardless of their treatment plan, which includes gastric balloon, surgical and medical or nutritional. Its Allurion Programme is offered in six months, 12 months and 12-18 months program.
Símbolo de cotizaciónALUR_t
Nombre de la empresaAllurion Technologies Inc
Fecha de salida a bolsaMar 29, 2021
Director ejecutivoDr. Shantanu Gaur, M.D.
Número de empleados- -
Tipo de seguridad- -
Fin del año fiscal- -
Dirección11 Huron Dr Ste 200
CiudadNATICK
Bolsa de valores- -
PaísUnited States of America
Código postal01760
Teléfono15086474000
Sitio Webhttps://www.allurion.com/en
Símbolo de cotizaciónALUR_t
Fecha de salida a bolsaMar 29, 2021
Director ejecutivoDr. Shantanu Gaur, M.D.
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos